Emerging Infections and Antibiotic Resistance- Pharmacist

  Price  

  Credits  2

This product is currently out of stock and unavailable.


Format
Resistant organisms, once confined to hospitals, are now being transmitted in the community. Initially reported in the 1980s, community-onset infections caused by these resistant organisms are an emerging public health concern. These infections contribute to escalating healthcare costs and in some cases, increased mortality. The media have highlighted MRSA in the community, referring to it as a “superbug.” Its transmission through close contact has increased the incidence of skin and soft tissue infections. Similar to MRSA, ESBL-producing Enterobacteriaceae were initially reported as hospital pathogens and are now found in the community as distinct clones. These infections are most often urinary tract infections caused by Escherichia coli that are resistant to the antibiotics typically used for empiric treatment. Also concerning is the escalating prevalence of C. difficile infection (CDI) in the community. In contrast to MRSA and ESBL-producing Enterobacteriaceae, this microbe is usually not antibiotic resistant. However, annual CDI death rates in the U.S. increased from about 6 per million people in 1999 to 24 per million in 2004. This issue reviews the risk factors and outpatient treatment challenges for each of the infections listed above. Currently recommended antibiotic regimens are discussed in detail.

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 0428-0000-11-106-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.